Dual-subtype FIV vaccine (Fel-O-Vax® FIV) protection against a heterologous subtype B FIV isolate

@article{Pu2005DualsubtypeFV,
  title={Dual-subtype FIV vaccine (Fel-O-Vax® FIV) protection against a heterologous subtype B FIV isolate},
  author={R. Pu and J. Coleman and J. Coisman and E. Sato and T. Tanabe and M. Arai and J. Yamamoto},
  journal={Journal of Feline Medicine and Surgery},
  year={2005},
  volume={7},
  pages={65 - 70}
}
Vaccine trials were undertaken to determine whether the Fel-O-Vax® FIV, a commercial dual-subtype (subtypes A and D) feline immunodeficiency virus (FIV) vaccine, is effective against a subtype B FIV isolate. Current results demonstrate the Fel-O-Vax FIV to be effective against a subtype B virus, a subtype reported to be the most common in the USA. 
View on SAGE
ncbi.nlm.nih.gov
54 Citations
Highly Influential Citations
2
Background Citations
14
Methods Citations
3
Results Citations
2

54 Citations

Citation Type

Citation Type

Dual-subtype feline immunodeficiency virus vaccine provides 12 months of protective immunity against heterologous challenge
  • 13
Feline immunodeficiency virus (FIV) vaccine efficacy and FIV neutralizing antibodies.
  • 19
Feline immunodeficiency virus model for designing HIV/AIDS vaccines.
  • 46
Vaccine protection against feline immunodeficiency virus: setting the challenge.
  • 34
Serological differentiation of FIV-infected cats from dual-subtype feline immunodeficiency virus vaccine (Fel-O-Vax FIV) inoculated cats.
  • 17
An updated nation-wide epidemiological survey of feline immunodeficiency virus (FIV) infection in Japan.
  • 22
Limited efficacy of an inactivated feline immunodeficiency virus vaccine
  • 49
Feline immunodeficiency virus pathogenesis and development of a dual-subtype feline-immunodeficiency-virus vaccine.
  • 64
Sequence variation of the feline immunodeficiency virus genome and its clinical relevance
  • 5
The protective rate of the feline immunodeficiency virus vaccine: An Australian field study.
  • 22
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 20 REFERENCES
Vaccination of cats against feline immunodeficiency virus (FIV): a matter of challenge.
  • 16
  • Highly Influential
Dual-subtype FIV vaccine protects cats against in vivo swarms of both homologous and heterologous subtype FIV isolates
  • 66
Perspectives on FIV vaccine development.
  • 45
FIV vaccine development and its importance to veterinary and human medicine: a review
  • 100
Cellular immune responses to feline immunodeficiency virus (FIV) induced by dual-subtype FIV vaccine.
  • 29
Vaccination with experimental feline immunodeficiency virus vaccines, based on autologous infected cells, elicits enhancement of homologous challenge infection.
  • 45
  • PDF
Enhancement after feline immunodeficiency virus vaccination.
  • 88
  • Highly Influential
Vaccination with Inactivated Virus but Not Viral DNA Reduces Virus Load following Challenge with a Heterologous and Virulent Isolate of Feline Immunodeficiency Virus
  • 51
  • PDF
Genetic diversity of feline immunodeficiency virus: dual infection, recombination, and distinct evolutionary rates among envelope sequence clades.
  • 159
  • PDF
MHC-restricted protection of cats against FIV infection by adoptive transfer of immune cells from FIV-vaccinated donors.
  • 22
...
1
2
...